Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
March-2020 Volume 19 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2020 Volume 19 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Cystatin C promotes cognitive dysfunction in rats with cerebral microbleeds by inhibiting the ERK/synapsin Ia/Ib pathway

  • Authors:
    • Guangna Yu
    • Xingyuan Sun
    • Li Li
    • Lijuan Huang
    • Hongbin Liu
    • Shuying Wang
    • Zhanjun Ren
    • Yanjiao Zhang
  • View Affiliations / Copyright

    Affiliations: Department of Physical Examination, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, Heilongjiang 161000, P.R. China, Director's Office, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, Heilongjiang 161000, P.R. China, First Department of Neurology, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, Heilongjiang 161000, P.R. China, Third Department of Neurology, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, Heilongjiang 161000, P.R. China, Department of Imagine, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, Heilongjiang 161000, P.R. China, Sixth Department of Neurology, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, Heilongjiang 161000, P.R. China
  • Pages: 2282-2290
    |
    Published online on: December 31, 2019
       https://doi.org/10.3892/etm.2019.8403
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Although higher serum level of cystatin C (CysC) was observed in patients with cerebral microbleeds, its associated role in the disease has not been elucidated. In this work, a rat model of cerebral microbleeds was created with the aim of investigating effects of CysC on cognitive function in rats with cerebral microbleeds and the underlying mechanism. Serum samples of patients with cerebral microbleeds and healthy people of the same age were collected. Levels of cystatin C expression in these samples were measured using CysC kits. Moreover, 48 spontaneously hypertensive rats (SHRs) bred under specific pathogen‑free (SPF) conditions were randomly divided into 4 groups: sham surgery control group (sham), model group (CMB), model + empty vector control group (CMB + vehicle), and model + cystatin C overexpression group (CMB + CysC). Expression levels of CysC in hippocampus of rats in each group were measured by western blot analysis. The Y‑maze was used to evaluate cognitive function of rats. Hippocampal long‑term potentiation (LTP) in rats was assessed by the electrophysiological assay. Alterations in levels of p‑ERK1/2 and p‑synapsin Ia/b proteins associated with cognitive function were identified by western blot analysis. The serum levels of CysC in patients with cerebral microbleeds were significantly upregulated (P<0.001). After injection of CysC, its expression levels in rat hippocampus were significantly increased (P<0.001), which enhanced the decline in learning and memory function, as well as the decrease of LTP in the rat model of cerebral microbleeds (P<0.001). Western blot results showed that injection of CysC further reduced the levels of p‑ERK1/2 and p‑synapsin Ia/b in the rat model of microbleeds (P<0.001). CysC was up regulated in serum of patients with cerebral microbleeds. It promoted cognitive dysfunction in rats with microbleeds by inhibiting ERK/synapsin Ia/Ib pathway.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Moulin S and Cordonnier C: Role of cerebral microbleeds for intracerebral haemorrhage and dementia. Curr Neurol Neurosci Rep. 19:512019. View Article : Google Scholar : PubMed/NCBI

2 

Cordonnier C, Al-Shahi Salman R and Wardlaw J: Spontaneous brain microbleeds: Systematic review, subgroup analyses and standards for study design and reporting. Brain. 130:1988–2003. 2007. View Article : Google Scholar : PubMed/NCBI

3 

Daugherty AM and Raz N: Incident risk and progression of cerebral microbleeds in healthy adults: A multi-occasion longitudinal study. Neurobiol Aging. 59:22–29. 2017. View Article : Google Scholar : PubMed/NCBI

4 

Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Niessen WJ, Hofman A, Krestin GP and Breteler MM: Prevalence and risk factors of cerebral microbleeds: The Rotterdam Scan Study. Neurology. 70:1208–1214. 2008. View Article : Google Scholar : PubMed/NCBI

5 

Charidimou A, Imaizumi T, Moulin S, Biffi A, Samarasekera N, Yakushiji Y, Peeters A, Vandermeeren Y, Laloux P, Baron JC, et al: Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: A meta-analysis. Neurology. 89:820–829. 2017. View Article : Google Scholar : PubMed/NCBI

6 

Charidimou A, Kakar P, Fox Z and Werring DJ: Cerebral microbleeds and recurrent stroke risk: Systematic review and meta-analysis of prospective ischemic stroke and transient ischemic attack cohorts. Stroke. 44:995–1001. 2013. View Article : Google Scholar : PubMed/NCBI

7 

Cordonnier C and van der Flier WM: Brain microbleeds and Alzheimer's disease: Innocent observation or key player? Brain. 134:335–344. 2011. View Article : Google Scholar : PubMed/NCBI

8 

Staekenborg SS, Koedam EL, Henneman WJ, Stokman P, Barkhof F, Scheltens P and van der Flier WM: Progression of mild cognitive impairment to dementia: Contribution of cerebrovascular disease compared with medial temporal lobe atrophy. Stroke. 40:1269–1274. 2009. View Article : Google Scholar : PubMed/NCBI

9 

Dierksen GA, Skehan ME, Khan MA, Jeng J, Nandigam RN, Becker JA, Kumar A, Neal KL, Betensky RA, Frosch MP, et al: Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy. Ann Neurol. 68:545–548. 2010. View Article : Google Scholar : PubMed/NCBI

10 

Gurol ME, Dierksen G, Betensky R, Gidicsin C, Halpin A, Becker A, Carmasin J, Ayres A, Schwab K, Viswanathan A, et al: Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy. Neurology. 79:320–326. 2012. View Article : Google Scholar : PubMed/NCBI

11 

Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, Launer LJ, Van Buchem MA and Breteler MM; Microbleed Study Group, : Cerebral microbleeds: A guide to detection and interpretation. Lancet Neurol. 8:165–174. 2009. View Article : Google Scholar : PubMed/NCBI

12 

Lawrence AJ, Patel B, Morris RG, MacKinnon AD, Rich PM, Barrick TR and Markus HS: Mechanisms of cognitive impairment in cerebral small vessel disease: Multimodal MRI results from the St. George's cognition and neuroimaging in stroke (SCANS) study. PLoS One. 8:e610142013. View Article : Google Scholar : PubMed/NCBI

13 

Lawrence AJ, Chung AW, Morris RG, Markus HS and Barrick TR: Structural network efficiency is associated with cognitive impairment in small-vessel disease. Neurology. 83:304–311. 2014. View Article : Google Scholar : PubMed/NCBI

14 

Poels MM, Ikram MA, van der Lugt A, Hofman A, Niessen WJ, Krestin GP, Breteler MM and Vernooij MW: Cerebral microbleeds are associated with worse cognitive function: The Rotterdam Scan Study. Neurology. 78:326–333. 2012. View Article : Google Scholar : PubMed/NCBI

15 

Leem AY, Park MS, Park BH, Jung WJ, Chung KS, Kim SY, Kim EY, Jung JY, Kang YA, Kim YS, et al: Value of serum Cystatin C measurement in the diagnosis of sepsis-induced kidney injury and prediction of renal function recovery. Yonsei Med J. 58:604–612. 2017. View Article : Google Scholar : PubMed/NCBI

16 

Benndorf RA: Renal Biomarker and Angiostatic Mediator? Cystatin C as a negative regulator of vascular endothelial cell homeostasis and angiogenesis. J Am Heart Assoc. 7:e0109972018. View Article : Google Scholar : PubMed/NCBI

17 

Ekström U, Wallin H, Lorenzo J, Holmqvist B, Abrahamson M and Avilés FX: Internalization of cystatin C in human cell lines. FEBS J. 275:4571–4582. 2008. View Article : Google Scholar : PubMed/NCBI

18 

Mathews PM and Levy E: Cystatin C in aging and in Alzheimer's disease. Ageing Res Rev. 32:38–50. 2016. View Article : Google Scholar : PubMed/NCBI

19 

Oh MY, Lee H, Kim JS, Ryu WS, Lee SH, Ko SB, Kim C, Kim CH and Yoon BW: Cystatin C, a novel indicator of renal function, reflects severity of cerebral microbleeds. BMC Neurol. 14:1272014. View Article : Google Scholar : PubMed/NCBI

20 

Yang S, Cai J, Lu R, Wu J, Zhang M and Zhou X: Association between serum cystatin C level and total magnetic resonance imaging burden of cerebral small vessel disease in patients with acute lacunar stroke. J Stroke Cerebrovasc Dis. 26:186–191. 2017. View Article : Google Scholar : PubMed/NCBI

21 

Zhang JB, Jü XH, Wang J, Sun HR and Li F: Serum cystatin C and cerebral microbleeds in patients with acute cerebral stroke. J Clin Neurosci. 21:268–273. 2014. View Article : Google Scholar : PubMed/NCBI

22 

Zhang JB, Liu LF, Li ZG, Sun HR and Jü XH: Associations between biomarkers of renal function with cerebral microbleeds in hypertensive patients. Am J Hypertens. 28:739–745. 2015. View Article : Google Scholar : PubMed/NCBI

23 

Fang Z, Deng J, Wu Z, Dong B, Wang S, Chen X, Nie H, Dong H, Xiong L and Cystatin C: Cystatin C is a crucial endogenous protective determinant against stroke. Stroke. 48:436–444. 2017. View Article : Google Scholar : PubMed/NCBI

24 

Zou J, Chen Z, Wei X, Chen Z, Fu Y, Yang X, Chen D, Wang R, Jenner P, Lu JH, et al: Cystatin C as a potential therapeutic mediator against Parkinson's disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular units. Cell Death Dis. 8:e28542017. View Article : Google Scholar : PubMed/NCBI

25 

Kono S, Adachi H, Enomoto M, Fukami A, Kumagai E, Nakamura S, Nohara Y, Morikawa N, Nakao E, Sakaue A, et al: Impact of cystatin C and microalbuminuria on cognitive impairment in the population of community-dwelling Japanese. Atherosclerosis. 265:71–77. 2017. View Article : Google Scholar : PubMed/NCBI

26 

Yin Z, Yan Z, Liang Y, Jiang H, Cai C, Song A, Feng L and Qiu C: Interactive effects of diabetes and impaired kidney function on cognitive performance in old age: A population-based study. BMC Geriatr. 16:72016. View Article : Google Scholar : PubMed/NCBI

27 

Stephan Y, Sutin AR and Terracciano A: Subjective age and cystatin C among older adults. J Gerontol B Psychol Sci Soc Sci. 74:382–388. 2019. View Article : Google Scholar : PubMed/NCBI

28 

Wei Y, Wei YK and Zhu J: Early markers of kidney dysfunction and cognitive impairment among older adults. J Neurol Sci. 375:209–214. 2017. View Article : Google Scholar : PubMed/NCBI

29 

Park YS, Chung MS and Choi BS: MRI assessment of cerebral small vessel disease in patients with spontaneous intracerebral hemorrhage. Yonsei Med J. 60:774–781. 2019. View Article : Google Scholar : PubMed/NCBI

30 

Tóth A, Berente Z, Bogner P, Környei B, Balogh B, Czeiter E, Amrein K, Dóczi T, Büki A and Schwarcz A: Cerebral microbleeds temporarily become less visible or invisible in acute susceptibility weighted magnetic resonance imaging: A Rat Study. J Neurotrauma. 36:1670–1677. 2019. View Article : Google Scholar : PubMed/NCBI

31 

Liu Y, Li J, Wang Z, Yu Z and Chen G: Attenuation of early brain injury and learning deficits following experimental subarachnoid hemorrhage secondary to cystatin C: Possible involvement of the autophagy pathway. Mol Neurobiol. 49:1043–1054. 2014. View Article : Google Scholar : PubMed/NCBI

32 

Li XH, Matsuura T, Liu RH, Xue M and Zhuo M: Calcitonin gene-related peptide potentiated the excitatory transmission and network propagation in the anterior cingulate cortex of adult mice. Mol Pain. Feb 28–2019.(Epub ahead of print). doi: 10.1177/1744806919832718, 2019. View Article : Google Scholar

33 

Pantoni L: Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 9:689–701. 2010. View Article : Google Scholar : PubMed/NCBI

34 

Dey AK, Stamenova V, Turner G, Black SE and Levine B: Pathoconnectomics of cognitive impairment in small vessel disease: A systematic review. Alzheimers Dement. 12:831–845. 2016. View Article : Google Scholar : PubMed/NCBI

35 

Roseborough A, Ramirez J, Black SE and Edwards JD: Associations between amyloid β and white matter hyperintensities: A systematic review. Alzheimers Dement. 13:1154–1167. 2017. View Article : Google Scholar : PubMed/NCBI

36 

Akoudad S, Wolters FJ, Viswanathan A, de Bruijn RF, van der Lugt A, Hofman A, Koudstaal PJ, Ikram MA and Vernooij MW: Association of cerebral microbleeds with cognitive decline and dementia. JAMA Neurol. 73:934–943. 2016. View Article : Google Scholar : PubMed/NCBI

37 

Cai Z, Wang C, He W, Tu H, Tang Z, Xiao M and Yan LJ: Cerebral small vessel disease and Alzheimer's disease. Clin Interv Aging. 10:1695–1704. 2015. View Article : Google Scholar : PubMed/NCBI

38 

Love S and Miners JS: Small vessel disease, neurovascular regulation and cognitive impairment: Post-mortem studies reveal a complex relationship, still poorly understood. Clin Sci (Lond). 131:1579–1589. 2017. View Article : Google Scholar : PubMed/NCBI

39 

Cobar LF, Yuan L and Tashiro A: Place cells and long-term potentiation in the hippocampus. Neurobiol Learn Mem. 138:206–214. 2017. View Article : Google Scholar : PubMed/NCBI

40 

Lømo T: Discovering long-term potentiation (LTP) - recollections and reflections on what came after. Acta Physiol (Oxf). 222:2222018. View Article : Google Scholar

41 

Abrahamson M, Alvarez-Fernandez M and Nathanson CM: Cystatins. Biochem Soc Symp. 70:179–199. 2003. View Article : Google Scholar

42 

Levy E, Jaskolski M and Grubb A: The role of cystatin C in cerebral amyloid angiopathy and stroke: Cell biology and animal models. Brain Pathol. 16:60–70. 2006. View Article : Google Scholar : PubMed/NCBI

43 

Tizon B, Sahoo S, Yu H, Gauthier S, Kumar AR, Mohan P, Figliola M, Pawlik M, Grubb A, Uchiyama Y, et al: Induction of autophagy by cystatin C: A mechanism that protects murine primary cortical neurons and neuronal cell lines. PLoS One. 5:e98192010. View Article : Google Scholar : PubMed/NCBI

44 

Zhang Y and Sun L: Cystatin C in cerebrovascular disorders. Curr Neurovasc Res. 14:406–414. 2017. View Article : Google Scholar : PubMed/NCBI

45 

Osk Snorradottir A, Isaksson HJ, Kaeser SA, Skodras AA, Olafsson E, Palsdottir A and Thor Bragason B: Parenchymal cystatin C focal deposits and glial scar formation around brain arteries in hereditary cystatin C amyloid angiopathy. Brain Res. 1622:149–162. 2015. View Article : Google Scholar : PubMed/NCBI

46 

Li J, Zhang M and Ma J: Myricitrin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation and migration through suppressing PDGFRβ/Akt/Erk signaling. Int J Clin Exp Med. 8:21715–21723. 2015.PubMed/NCBI

47 

Frost EE, Zhou Z, Krasnesky K and Armstrong RC: Initiation of oligodendrocyte progenitor cell migration by a PDGF-A activated extracellular regulated kinase (ERK) signaling pathway. Neurochem Res. 34:169–181. 2009. View Article : Google Scholar : PubMed/NCBI

48 

Horikawa J and Ojima H: Cortical activation patterns evoked by temporally asymmetric sounds and their modulation by learning. eNeuro. 4:42017. View Article : Google Scholar

49 

Atkins CM, Selcher JC, Petraitis JJ, Trzaskos JM and Sweatt JD: The MAPK cascade is required for mammalian associative learning. Nat Neurosci. 1:602–609. 1998. View Article : Google Scholar : PubMed/NCBI

50 

English JD and Sweatt JD: A requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation. J Biol Chem. 272:19103–19106. 1997. View Article : Google Scholar : PubMed/NCBI

51 

Selcher JC, Atkins CM, Trzaskos JM, Paylor R and Sweatt JD: A necessity for MAP kinase activation in mammalian spatial learning. Learn Mem. 6:478–490. 1999. View Article : Google Scholar : PubMed/NCBI

52 

Chernigovskaya EV, Korotkov AA, Dorofeeva NA, Gorbacheva EL, Kulikov AA and Glazova MV: Delayed audiogenic seizure development in a genetic rat model is associated with overactivation of ERK1/2 and disturbances in glutamatergic signaling. Epilepsy Behav. 99:1064942019. View Article : Google Scholar : PubMed/NCBI

53 

Song SH and Augustine GJ: Synapsin isoforms and synaptic vesicle trafficking. Mol Cells. 38:936–940. 2015. View Article : Google Scholar : PubMed/NCBI

54 

Lugarà E, De Fusco A, Lignani G, Benfenati F, Humeau Y and Synapsin I: Synapsin I controls synaptic maturation of long-range projections in the lateral amygdala in a targeted selective fashion. Front Cell Neurosci. 13:2202019. View Article : Google Scholar : PubMed/NCBI

55 

Marte A, Russo I, Rebosio C, Valente P, Belluzzi E, Pischedda F, Montani C, Lavarello C, Petretto A, Fedele E, et al: Leucine-rich repeat kinase 2 phosphorylation on synapsin I regulates glutamate release at pre-synaptic sites. J Neurochem. 150:264–281. 2019. View Article : Google Scholar : PubMed/NCBI

56 

Cui Y, Costa RM, Murphy GG, Elgersma Y, Zhu Y, Gutmann DH, Parada LF, Mody I and Silva AJ: Neurofibromin regulation of ERK signaling modulates GABA release and learning. Cell. 135:549–560. 2008. View Article : Google Scholar : PubMed/NCBI

57 

Giachello CN, Fiumara F, Giacomini C, Corradi A, Milanese C, Ghirardi M, Benfenati F and Montarolo PG: MAPK/Erk-dependent phosphorylation of synapsin mediates formation of functional synapses and short-term homosynaptic plasticity. J Cell Sci. 123:881–893. 2010. View Article : Google Scholar : PubMed/NCBI

58 

Chen X, Wang X, Yang Y, Li Z, Zhang Y, Gao W, Xiao J and Li B: Schwann cells protect against CaMKII- and PKA-dependent acrylamide-induced synapsin I phosphorylation. Brain Res. 1701:18–27. 2018. View Article : Google Scholar : PubMed/NCBI

59 

Verstegen AM, Tagliatti E, Lignani G, Marte A, Stolero T, Atias M, Corradi A, Valtorta F, Gitler D, Onofri F, et al: Phosphorylation of synapsin I by cyclin-dependent kinase-5 sets the ratio between the resting and recycling pools of synaptic vesicles at hippocampal synapses. J Neurosci. 34:7266–7280. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Yu G, Sun X, Li L, Huang L, Liu H, Wang S, Ren Z and Zhang Y: Cystatin C promotes cognitive dysfunction in rats with cerebral microbleeds by inhibiting the ERK/synapsin Ia/Ib pathway. Exp Ther Med 19: 2282-2290, 2020.
APA
Yu, G., Sun, X., Li, L., Huang, L., Liu, H., Wang, S. ... Zhang, Y. (2020). Cystatin C promotes cognitive dysfunction in rats with cerebral microbleeds by inhibiting the ERK/synapsin Ia/Ib pathway. Experimental and Therapeutic Medicine, 19, 2282-2290. https://doi.org/10.3892/etm.2019.8403
MLA
Yu, G., Sun, X., Li, L., Huang, L., Liu, H., Wang, S., Ren, Z., Zhang, Y."Cystatin C promotes cognitive dysfunction in rats with cerebral microbleeds by inhibiting the ERK/synapsin Ia/Ib pathway". Experimental and Therapeutic Medicine 19.3 (2020): 2282-2290.
Chicago
Yu, G., Sun, X., Li, L., Huang, L., Liu, H., Wang, S., Ren, Z., Zhang, Y."Cystatin C promotes cognitive dysfunction in rats with cerebral microbleeds by inhibiting the ERK/synapsin Ia/Ib pathway". Experimental and Therapeutic Medicine 19, no. 3 (2020): 2282-2290. https://doi.org/10.3892/etm.2019.8403
Copy and paste a formatted citation
x
Spandidos Publications style
Yu G, Sun X, Li L, Huang L, Liu H, Wang S, Ren Z and Zhang Y: Cystatin C promotes cognitive dysfunction in rats with cerebral microbleeds by inhibiting the ERK/synapsin Ia/Ib pathway. Exp Ther Med 19: 2282-2290, 2020.
APA
Yu, G., Sun, X., Li, L., Huang, L., Liu, H., Wang, S. ... Zhang, Y. (2020). Cystatin C promotes cognitive dysfunction in rats with cerebral microbleeds by inhibiting the ERK/synapsin Ia/Ib pathway. Experimental and Therapeutic Medicine, 19, 2282-2290. https://doi.org/10.3892/etm.2019.8403
MLA
Yu, G., Sun, X., Li, L., Huang, L., Liu, H., Wang, S., Ren, Z., Zhang, Y."Cystatin C promotes cognitive dysfunction in rats with cerebral microbleeds by inhibiting the ERK/synapsin Ia/Ib pathway". Experimental and Therapeutic Medicine 19.3 (2020): 2282-2290.
Chicago
Yu, G., Sun, X., Li, L., Huang, L., Liu, H., Wang, S., Ren, Z., Zhang, Y."Cystatin C promotes cognitive dysfunction in rats with cerebral microbleeds by inhibiting the ERK/synapsin Ia/Ib pathway". Experimental and Therapeutic Medicine 19, no. 3 (2020): 2282-2290. https://doi.org/10.3892/etm.2019.8403
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team